Skip to main content
. Author manuscript; available in PMC: 2014 Jul 15.
Published in final edited form as: Int J Pediatr Otorhinolaryngol. 2012 Oct 31;77(1):123–127. doi: 10.1016/j.ijporl.2012.10.009

Table 3.

Results of association analysis of candidate genes with nominal p values ≤0.05. SNP: single nucleotide polymorphism. Major allele: most frequent in sample. Minor allele: least frequent in sample. OR: odds ratio. χ2: chi square statistic. P: nominal p value. EMP: empirical p value after permutation analysis.

Gene (band) SNP (position) Role Major
Allele
Minor
Allele
Minor
Allele
Relative
Frequency
Cases
Minor
Allele
Relative
Frequency
Controls
Genotype
Count
Cases
Genotype
Count
Controls
OR χ2 P EMP
IRF6 (1q32.2) rs2235372 (208027059) Near-gene-3 G A 0.25 0.12 2/15/21 0/15/48 2.47 5.81 0.02 0.06
rs742215 (208027646) Near-gene-3 A T 0.25 0.12 2/15/21 0/15/48 2.47 5.81 0.02 0.06
rs17317411 (208027937) Untranslated-3 T C 0.22 0.08 2/13/23 0/11/52 3.01 7.39 0.007 0.03
rs17015218 (208034538) Intron A G 0.24 0.10 2/14/22 0/13/50 2.70 6.52 0.01 0.04
rs17015226 (208036719) Intron C G 0.24 0.10 2/14/22 0/13/50 2.70 6.52 0.01 0.04
rs6540560 (208048696) Unknown C T 0.24 0.10 2/14/22 0/13/50 2.70 6.52 0.01 0.04
rs6696825 (208048995) Unknown A G 0.25 0.12 2/15/21 0/15/48 2.47 5.81 0.02 0.06
TGFA (2p13.3) rs432203 (70618196) Intron G T 0.54 0.37 11/18/8 12/23/28 1.98 5.32 0.02 0.29
rs377122 (70620533) Intron C T 0.53 0.37 11/18/9 12/23/28 1.87 4.54 0.03 0.47
SATB2 (2q33.1) rs4673309 (199855654) Intron A G 0.21 0.08 1/14/23 0/10/53 3.10 7.27 0.007 0.04
rs10497832 (199875181) Intron G C 0.21 0.08 1/14/23 0/10/53 3.10 7.27 0.007 0.04
rs1374361 (199878979) Intron C T 0.18 0.08 1/12/25 0/10/53 2.62 4.98 0.03 0.14
rs4675475 (199884288) Intron G T 0.30 0.18 2/19/17 1/21/41 1.94 3.89 0.05 0.28
rs7569519 (199888067) Intron A C 0.30 0.18 2/19/17 1/21/41 1.94 3.89 0.05 0.28
rs930616 (199894160) Intron A G 0.30 0.18 2/19/17 1/21/41 1.94 3.89 0.05 0.28
rs17197938 (199908430) Intron C T 0.12 0.25 0/9/29 2/28/33 0.39 5.38 0.02 0.12
rs16831370 (199939292) Intron C G 0.01 0.07 0/1/37 0/10/53 0.15 4.04 0.04 0.26
rs10497836 (199996963) Intron T C 0.39 0.24 4/22/12 2/26/35 2.09 5.57 0.02 0.12
rs895882 (200011260) Intron A G 0.39 0.24 4/22/12 2/26/35 2.09 5.57 0.02 0.12
rs13392032 (200017738) Intron C G 0.29 0.17 1/20/17 3/15/45 2.04 4.27 0.04 0.21
MTRR (5p15.31) rs17184211 (7919106) Intron A T 0.14 0.27 3/5/30 3/28/31 0.45 4.53 0.03 0.23
FGF10 (5p12) rs17234541 (44344655) Intron G T 0.01 0.11 0/1/37 2/10/51 6.62 0.11 0.01 0.08
rs17234079 (4497961) Intron C T 0.28 0.10 2/17/19 1/11/51 3.32 10.15 0.001 0.01
rs10512852 (44429326) Unknown T C 0.01 0.17 0/1/37 3/16/44 0.06 12.25 0.0005 0.005
ESR1 (6q25.1) rs1543403 (152470397) Unknown G C 0.59 0.44 12/21/5 10/36/17 1.82 4.14 0.04 0.63
FGFR2 (10q26.13) rs1649202 (123230615) Intron C T 0.50 0.31 11/16/11 6/26/30 2.26 7.49 0.006 0.06
rs2278202 (123233187) Intron A G 0.46 0.26 8/19/11 4/25/34 2.41 8.38 0.004 0.04
FGF3 (11q13.3) rs12577891 (69332822) Near-gene-3 G T 0.29 0.17 7/8/23 2/17/44 2.04 4.27 0.04 0.20
rs10908228 (69336099) Intron C T 0.29 0.17 7/8/23 2/17/44 2.04 4.27 0.04 0.20
PVRL1 (11q23.3) rs10790332 (119058888) Intron T C 0.36 0.50 5/17/16 13/37/13 0.55 4.02 0.05 0.19
rs4936492 (119065659) Intron G A 0.36 0.52 5/17/16 15/35/13 0.52 4.93 0.03 0.12
rs7950059 (119070705) Intron C T 0.38 0.54 6/17/15 15/38/10 0.53 4.75 0.03 0.13
rs1467051 (119073511) Intron G A 0.35 0.53 5/16/16 13/39/9 0.48 6.10 0.01 0.07
rs7945395 (119074947) Intron A G 0.34 0.53 6/14/18 14/39/10 0.46 6.87 0.009 0.04
rs7945424 (119075012) Intron G T 0.33 0.54 5/14/17 14/40/9 0.43 7.84 0.005 0.02
rs715849 (119080934) Intron G A 0.34 0.52 6/14/18 13/40/10 0.47 6.31 0.01 0.06
CBS (21q22.3) rs2839631 (43343155) Unknown C T 0.46 0.33 7/21/10 5/31/27 1.77 3.69 0.05 0.22
rs9325622 (43352770) Intron G A 0.46 0.32 7/21/10 5/30/28 1.84 4.16 0.04 0.19
rs1789953 (43356005) Intron T C 0.07 0.18 0/5/33 2/19/42 0.32 5.41 0.02 0.10
HHS Vulnerability Disclosure